首页 - 股票 - 研报 - 行业研究 - 正文

China insurance:Time to explore P&C

关注证券之星官方微博:

Prefer P&C over life on visible earnings and valuation.

The market has shown a strong risk appetite since the rate cut, buying uplife insurers despite lack of further fundamental improvement. While weraise TP across the board on MTM gain and higher multiple, the upsidelooks stretched. We keep the UW view and downgrade NCI to SELL fromU-PF. By contrast, P&C offers more opportunities due to better earningsvisibility and less demanding valuation. We upgrade PICC P&C to O-PFfrom U-PF; and keep the BUY call for Ping An.

Improving sentiment on life.

Life insurers have had a great run following the rate cut. Though the outlook isclearly better than a year ago, the shares have run ahead of fundamentals.

We keep NBV forecast unchanged but raise multiples on more risk appetite.

Together with adjustment in 2014 MTM, TP goes up across the board.

Yet, the upside still looks stretched. We downgrade NCI to SELL from U-PF.

Pressure on life margin.

While life insurers do benefit from MTM, we shall not expect much increase in profitor book as they have to share at least 70% of the gain with customers.

Besides, there would be investment yield pressure from lower interest rates andfurther pricing liberalization.

To compete with other financial products, life insurers have to keep policyholderreturn high and margin will be squeezed.

Better earnings visibility in P&C.

Life earnings are too dependent on markets and therefore volatile. By contrast, P&Cenjoys better visibility as the risk underwriting provides a solid profit anchor.

For PICC P&C, underwriting accounts for about 40% of operating profit. Thoughcombined ratio is to rise, the company can stay disciplined and keep it under 100%.

ROE, despite trending down, will still beat life’s. After the strong rally in life, P&Coffers better opportunities.

Top picks – Ping An and PICC P&C.

We upgrade PICC P&C to O-PF from U-PF. The stock trades at 1.8x PB with ROE of16.5%, less demanding than its life peers at 1.6-2.3x PB and ROE of 9-15% ROE.

For Ping An, we raise the TP to HK$101 from HK$80 after removing the discount forfundraising. We continue to be a BUYer of this stock.

We do recognize the strong trading momentum on pure life names. However, PICCP&C and Ping An offer more solid LT investment in the insurance space.





微信
扫描二维码
关注
证券之星微信
APP下载
下载证券之星
郑重声明:以上内容与证券之星立场无关。证券之星发布此内容的目的在于传播更多信息,证券之星对其观点、判断保持中立,不保证该内容(包括但不限于文字、数据及图表)全部或者部分内容的准确性、真实性、完整性、有效性、及时性、原创性等。相关内容不对各位读者构成任何投资建议,据此操作,风险自担。股市有风险,投资需谨慎。如对该内容存在异议,或发现违法及不良信息,请发送邮件至jubao@stockstar.com,我们将安排核实处理。
网站导航 | 公司简介 | 法律声明 | 诚聘英才 | 征稿启事 | 联系我们 | 广告服务 | 举报专区
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-